Amar Sawhney

There is a strong demand for Ocular Therapeutix Inc (NASDAQ: OCUL) shares in the pre-market trading after the company revealed a tactical collaboration, option and license deal with Regeneron Pharmaceuticals Inc (NASDAQ: REGN). Ocular stock surged more than 25 percent. According to the agreement...